Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials.
about
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipientsSirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results.Effectiveness and safety of calcineurin inhibitor withdrawal in kidney transplantation: a meta-analysis of randomized controlled trials.Subclinical toxicity of calcineurin inhibitors in repeated protocol biopsies: an independent risk factor for chronic kidney allograft damageA prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.Mycophenolate mofetil and sirolimus combination in renal transplantation.Need for quality improvement in renal systematic reviews.Fibrogenesis in kidney transplantation: potential targets for prevention and therapy.Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen.Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment.Long-term management of the kidney transplant recipient.Is it time to give up with calcineurin inhibitors in kidney transplantation?Cardiovascular morbidity and mortality after kidney transplantation.Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial.Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation.Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow UpUse of mTOR inhibitors in human organ transplantation.The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients.Sirolimus treatment of left ventricular hypertrophy: who, and when?Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies.Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models.
P2860
Q24246340-8DE3BECB-A235-42E6-B013-2053B1F2E5C2Q33376348-15EEB8B1-7EFE-4115-BD65-ED747E1353B5Q33421541-DE6180DC-2E72-4AC9-88C9-894B31AD70C2Q33815032-A402F07A-06BC-4F39-9912-C7103B79E891Q36183858-EDAA1B70-CBF1-4770-A3EA-900BC3B49194Q36575992-561B3CC3-01C5-4138-9312-75AB85E070EBQ36736617-8B5D84A7-D0A3-45AE-A161-1665A29ED91AQ37638064-89BDF6B7-8DE8-426C-87B2-B91C974625EAQ37860391-D1CE885D-E63A-4FC3-B9B4-A58C290723F2Q37873950-452C1C10-66C3-459C-AE6F-305E72208BA4Q37978101-D9694F18-9EE4-416E-B806-ED030E1EE28FQ38156847-97E229EA-3AB2-4B5F-979B-74C777FD05CCQ38235860-58C1B957-F560-4127-BC7E-D36ED80EA976Q40505344-8DEEB9E4-4488-482C-BEDB-01B31E7477E9Q42078849-937D30DD-3DBB-4989-A6DD-5AADE8B99745Q42612170-31D041F2-EE1B-4B98-B12D-BD0017082D37Q43061556-B104FAB6-C268-4469-B81B-C2F51A80468CQ46233987-7CCF74E6-DCEE-4880-A73E-610420E6BFC4Q46308476-6043615E-0270-4EB7-8262-0F506150D11BQ46667111-949A1660-614D-4A4C-96C1-9F121463B8FBQ46753398-715BE3FF-66B2-421D-9997-22B66298C014Q54265850-A094C48A-E2F7-4A42-B9B0-D8C1769C738F
P2860
Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Calcineurin inhibitor withdraw ...... c review of randomized trials.
@ast
Calcineurin inhibitor withdraw ...... c review of randomized trials.
@en
type
label
Calcineurin inhibitor withdraw ...... c review of randomized trials.
@ast
Calcineurin inhibitor withdraw ...... c review of randomized trials.
@en
prefLabel
Calcineurin inhibitor withdraw ...... c review of randomized trials.
@ast
Calcineurin inhibitor withdraw ...... c review of randomized trials.
@en
P2093
P2860
P1476
Calcineurin inhibitor withdraw ...... c review of randomized trials.
@en
P2093
Atul V Mulay
Dean Fergusson
Greg A Knoll
Naser Hussain
P2860
P304
P356
10.1111/J.1600-6143.2005.00931.X
P407
P577
2005-07-01T00:00:00Z